“We are looking for older volunteers with MCI or mild dementia due to AD or Lewy body dementia, and healthy older individuals, who wish…
About seven out of ten cases of Alzheimer’s are accompanied by symptoms of agitation and aggression. This could mean pacing, restlessness, shouting and screaming,…
Hours feel like days. Days feel like months. And months? Well they can feel like a decade. Particularly when you are awaiting the restart…
The response was disappointing but not particularly surprising. Earlier in the day, I had sent a quick email to check in with the staff…
Jeff Borghoff today took yet another small step toward finding a cure for Alzheimer’s disease as he became the first person in the world…
Almost a year ago, the phones and social media feeds of about 4,000 people around the world began to explode. Biogen had unexpectedly—and quite…
The world of developing drugs to fight beta-amyloid has been on a rollercoaster ride the last year, but some scientists aren’t giving up. Researchers…
Researchers announced today that an Alzheimer’s clinical trial spearheaded by Washington University School of Medicine in St. Louis has been cancelled. Initial data analysis…
An Alzheimer’s drug that attacks tau proteins is now being moved into new clinical trials in the U.S. and Europe, according to Singapore-based pharmaceutical…
In a new study published in JAMA Neurology, researchers reported the first results of an initial basket trial for neurodegenerative diseases. The trial brings…
Building on research into the connection between dementia, inflammation and bacteria in our digestive systems, Chinese officials awarded conditional approval to a seaweed-based drug…
New research suggests that the common blood pressure drug nilvadipine boosts blood flow to the brain in people with Alzheimer’s, which could potentially slow…
The anesthetic drug xenon increases life expectancy and prevents long-term cognitive impairment following a traumatic brain injury (TBI) in mice, according to a new…
Earlier this year, the F.D.A. issued a warning to Ambrosia, a company that was selling plasma transfusions of “young blood” to elderly people, suggesting…
It hasn’t been a great year for Alzheimer’s drugs—or really a great decade, even. The most recent Phase 3 trial cancellation was a study…